Raffles Associates’s DNA X SONM Stock Holding History
Bought
Maintained
Sold
Other funds holding SONM
MHP
Raffles Associates's SONM Position: Q1 2021 in Review
Raffles Associates sold out of DNA X (SONM) in Q1 2021, closing a stake of 167 shares — an estimated $218K sold.
Raffles Associates first reported a position in SONM in Q3 2020 and held it in 2 quarters. The position peaked at $350K in Q3 2020. 23 funds tracked by Wall St. Rank hold SONM as of Q1 2021.
- Raffles Associates reported no remaining DNA X position as of Q1 2021 after selling out during the quarter.
- Raffles Associates sold 167 DNA X shares in Q1 2021, an estimated $218K.
- Raffles Associates first reported a position in DNA X in Q3 2020 and held it in 2 quarters.
- Raffles Associates's DNA X position peaked at $350K in Q3 2020.
- 23 funds tracked by Wall St. Rank held DNA X as of Q1 2021.
Based on Raffles Associates's 13F filing for Q1 2021, filed 17 May 2021.